Novo Nordisk (NOVO) is to launch Wegovy in Japan next year. Tom White discusses this as the majority of Japan patients will pay 30% of medical expenses for Wegovy. This will be the first Wegovy Asian product launch. White also talks about how McDonald’s (MCD) expands its ownership stake in its China business. Tune in to find out more about the stock market today.
Trading 360
24 Nov 2023
SHARE